Navigation Links
PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
Date:12/1/2008

BOSTON, Dec. 1 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today it will be presenting at the NASDAQ OMX 22nd Investor Program in London, England. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a formal presentation on PAREXEL at 10:45 a.m. GMT on Thursday, December 4, 2008. A live webcast of this presentation will be available under the "Upcoming Events" section on PAREXEL's "Investors" homepage at www.PAREXEL.com. A replay of the presentation will be available until December 4, 2009.

About the Company

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has over 9,180 employees. For more information about PAREXEL International visit www.parexel.com.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All othe
'/>"/>

SOURCE PAREXEL International
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
2. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
3. PAREXEL International to Present at Bank of America 2008 Smid Cap Conference
4. International Medical Corps Launches Online Catalog Offering Gifts That Save the Lives of Those in Need
5. International workshop aims to boost public engagement work in developing countries
6. BET Networks Joins the International Call to Stop the Spread of HIV on World AIDS Day Monday, December 1 with a Special Episode of 106 & PARK Followed by BET News Exclusive ARE YOU POSITIVE?
7. Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
8. International Formula Council Statement on Melamine and Infant Formulas
9. Pulmonary Hypertension Treated with Stem Cells : International Medical Team Announces Patient Results in Adult Stem Cell Clinical Study for Pulmonary Hypertension
10. MINRAD International, Inc. Announces Termination of RxElite Holdings Inc. as Anesthetics Distributor for the Human Market in United States
11. Lights Out For Bed Bugs as "BEST YET" Cedar Oil Solution Solves International Bed Bug Dilemma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...ewswire/ -- The Pew Charitable Trusts announced to...emical and food safety programs, in its Health &am...ormerly deputy staff director and general counsel ...Works, brings nearly 25 years of experience in env..., , "We are excited to be joined by such an expe...
(Date:1/8/2009)...rstCall/ -- Cephalon, Inc . (Nasdaq: CEPH ) tod...man and CEO will present at the J.P. Morgan Healt...n San Francisco, CA at approximately 4:00 p.m. Pac...will be webcast live on the investor relations sec... will be archived for one week following the broad...
(Date:1/8/2009)...e-FirstCall/ -- Heska Corporation (Nasdaq: HSKA ...hat: Heska Corporation Invites You to Join Its...arnings Conference Call on the Web, When: ...Where: www.heska.com (click on the Q4 and Year-...front page of this website)., How: Live...
(Date:1/8/2009)...wire/ -- St. Jude Children,s Research,Hospital(R)...Cup Runner-Up,Camilo Villegas has increased his c... match Singh,s donation of $5,000 to St. Jude for ...s for St. Jude is a powerful program that,has uni...sing LPGA star Morgan,Pressel, along with the Gol...
Breaking Medicine News(10 mins):Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 2Health News:Cephalon, Inc. to Present at the J.P. Morgan Healthcare Conference 3Health News:Webcast Alert: Heska Announces Fourth Quarter and Year-End 2008 Earnings Conference Call Webcast 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4
...o latest research , sudden emotional stress can re...s that mimics a classic heart attack.// Stress ca...sive heart attack. According to the researchers, p...rge in adrenalin and other stress hormones that te...
...ndings of a recent study researchers say , cancer ...us thrombosis, // or blood clots in the legs or lu...o 70, who had a blood clot in their legs or lungs....he presence of distant metastases, and carrier sta...
...world congress for diabetes begins in Chennai toda...betes and its complications //and over 1000 doctor...untries across the world. The world congress for...very three years, since the time of its inception ...
...tion therapy is used to treat deep vein thrombosis...is or arms. Researchers say several new studies sh...plify anticoagulation therapy.// In the first stu...hrombosis) patients and compared the effectiveness...
Other Medicine News:
(Date:1/8/2009)... initial dose in an ongoing Phase Ib trial demonst...three days , , Conference Call Today at 8:30AM ...l/ -- Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS...f an ongoing Phase Ib clinical trial of ANA598, th...ase inhibitor. ANA598 was very well-tolerated and...
(Date:1/7/2009)...ts in Development Based On Osteotech,s Proprietary...oRegeneration; FDA Filing Anticipated in Third Qua...ire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OST...oducts for regenerative healing, announced today t...its DuraTech(TM) BioRegeneration Matrix. The first...
(Date:1/6/2009)...PRNewswire/ -- In recent controlled studies conduc... , scientists found that the patented ingredient i...ly proven ingredient to increase levels of nitric ...itrate/nitrate (NOx) in human subjects. , , Nit...rease in blood flow to the skeletal muscles. This...
(Date:1/6/2009)...ary 6 , - Early R...n Until,December 2011 , - Expansion of the...iscovery in Ophthalmology , - Revised Comme...ublicenses to a Third Party , ExonHit The...nforcement,of its existing drug discovery collabo...
Breaking Medicine Technology:ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 2ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 3ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 4ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 5ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients 6Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 2Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix 3US Testing Proves Glyc'n Go(TM) Increases NO in the Blood Stream 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 1Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 2Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 3Nexia Closes Acquisition of Green Endeavors 3B Landis Salons On Track to Generate Revenues of 242 2 Million in 2007 4148 4Maxygen Third Quarter 2007 Financial Results Conference Call Notice 1375 1Maxygen Third Quarter 2007 Financial Results Conference Call Notice 1375 2AQUISS Continues Expansion Into New Territory 1372 1AQUISS Continues Expansion Into New Territory 1372 2Key found to moonlight romance 889 1Key found to moonlight romance 889 2Key found to moonlight romance 889 3
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: